|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.30 SAR | -1.58% |
|
+1.80% | -1.04% |
| 01-02 | AlphaMena Lowers Dallah Healthcare PT, Keeps Reduce Rating | MT |
| 12-24 | Dallah Healthcare Concludes Purchase of Remaining Care Shield Stake | MT |
| Capitalization | 12.78B 3.41B 2.92B 2.72B 2.53B 4.73B 308B 5.1B 31.3B 12.32B 147B 12.52B 539B | P/E ratio 2025 * |
22.8x | P/E ratio 2026 * | 20.8x |
|---|---|---|---|---|---|
| Enterprise value | 15.57B 4.15B 3.56B 3.32B 3.09B 5.76B 375B 6.21B 38.14B 15.01B 179B 15.25B 657B | EV / Sales 2025 * |
3.86x | EV / Sales 2026 * | 3.45x |
| Free-Float |
41.85% | Yield 2025 * |
1.71% | Yield 2026 * | 1.72% |
| 1 day | -1.66% | ||
| 1 week | +1.80% | ||
| Current month | -1.04% | ||
| 1 month | +1.31% | ||
| 3 months | -19.82% | ||
| 6 months | -1.43% | ||
| Current year | -1.04% |
| 1 week | 122.1 |  | 127.7 |
| 1 month | 117.4 | | 132.5 |
| Current year | 118.2 | | 127.7 |
| 1 year | 109 | | 161.2 |
| 3 years | 109 | | 194 |
| 5 years | 48.95 | | 194 |
| 10 years | 32.45 | | 194 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 29/03/2008 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mohialdeen Kamel
BRD | Director/Board Member | 44 | 21/10/2016 |
| Chairman | 69 | 01/01/1994 | |
Amr Kamel
BRD | Director/Board Member | - | 21/10/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 0.03% | 1 M€ | |
| +4.72% | 0.02% | 51 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.58% | +1.80% | -20.28% | -10.52% | 3.41B | |
| -0.12% | -1.05% | +19.01% | +41.54% | 18.43B | |
| -1.01% | +4.09% | -7.50% | -54.83% | 15.62B | |
| -0.53% | -2.35% | +8.43% | +67.74% | 11.58B | |
| -0.16% | -0.45% | +33.02% | +80.23% | 10.21B | |
| -0.08% | -5.78% | +7.69% | +64.24% | 10.08B | |
| +2.27% | -7.69% | -23.08% | -40.50% | 9.1B | |
| -0.40% | -3.89% | -31.58% | - | 7.5B | |
| +0.21% | -3.28% | +37.13% | +216.34% | 7.61B | |
| +0.22% | +3.25% | +6.38% | -45.11% | 5.65B | |
| Average | -0.11% | -1.61% | +2.92% | +35.46% | 9.92B | |
| Weighted average by Cap. | -0.10% | -1.60% | +5.53% | +34.33% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.03B 1.08B 923M 859M 800M 1.49B 97.1B 1.61B 9.88B 3.89B 46.45B 3.95B 170B | 4.44B 1.18B 1.01B 945M 879M 1.64B 107B 1.77B 10.86B 4.27B 51.07B 4.34B 187B |
| Net income | 540M 144M 123M 115M 107M 200M 12.99B 215M 1.32B 520M 6.21B 528M 22.77B | 607M 162M 139M 129M 120M 224M 14.6B 242M 1.49B 585M 6.99B 594M 25.6B |
| Net Debt | 2.79B 744M 639M 595M 553M 1.03B 67.2B 1.11B 6.84B 2.69B 32.14B 2.73B 118B | 2.52B 673M 578M 538M 500M 934M 60.77B 1.01B 6.18B 2.43B 29.07B 2.47B 107B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 124.30 ﷼ | -1.58% | 8,860 |
| 14/01/26 | 126.30 ﷼ | -0.47% | 51,137 |
| 13/01/26 | 126.90 ﷼ | -0.63% | 94,022 |
| 12/01/26 | 127.70 ﷼ | +2.16% | 48,299 |
| 11/01/26 | 125.00 ﷼ | +2.46% | 32,924 |
Delayed Quote Saudi Arabian S.E., January 15, 2026 at 10:38 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4004 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition